arrow
K

Kaj Blennow

the sahlgrenska academy at the university of gothenburg
H指数:214
被引数:23.2万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alzheimer’s disease genetics converges on microglial and neuronal dysregulation

阿尔茨海默病遗传学研究聚焦于小胶质细胞和神经元功能失调

Nature
IF48.5
2026-10-280
OAAI
Locus coeruleus activity is related to sleep and 24-h rest-activity rhythms in the context of plasma Alzheimer’s disease markers: a 7T MRI study of older individuals

蓝斑活动与血浆阿尔茨海默病标志物背景下的睡眠和24小时休息-活动节律相关:一项针对老年人的7T MRI研究

2026-10-010
OA
A centiloid-scaled crossover of amyloid and tau influences on plasma p-Tau217 along the Alzheimer’s disease continuum

阿尔茨海默病连续谱中,以百分之一洛德为单位计的淀粉样蛋白和tau蛋白影响对血浆p-Tau217的交叉影响

2026-09-290
OAAI
Circulating Metabolite Signatures Associated With Amyloid Positivity, Cognitive Performance and Plasma P-tau181 Levels in Cognitively Unimpaired Older Adults

与淀粉样蛋白阳性、认知表现和血浆P-tau181水平相关的循环代谢物特征在认知功能完好老年人中的研究

2026-09-140
OAAI
CSF p-tau205: a biomarker of Alzheimer’s disease progression and biological staging

脑脊液p-tau205:阿尔茨海默病进展和生物学分期的生物标志物

2026-08-270
OA
Cerebrospinal fluid biomarkers reveal transdiagnostic synaptic dysfunction across major psychiatric disorders

脑脊液生物标志物揭示主要精神疾病跨诊断的突触功能障碍

2026-07-300
OA
Spatiotemporal dynamics of tau extent and load increase in Alzheimer’s disease across four longitudinal cohorts

阿尔茨海默病中tau蛋白范围和负荷增加的时空动态变化:基于四项纵向队列研究

2026-07-140
OAAI
Gut bacterial metabolite imidazole propionate potentiates Alzheimer’s disease pathology

肠道细菌代谢物咪唑丙酸盐加剧阿尔茨海默病病理

2026-06-260
OAAI
Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease

循环鞘磷脂与认知未受损且具有阿尔茨海默病风险的老年人群的血浆总tau蛋白相关

2026-05-080
OA
GWAS meta-analysis of cerebrospinal fluid Alzheimer’s biomarkers reveals loci regulating lipids, brain volume and autophagy

脑脊液阿尔茨海默病生物标志物的GWAS荟萃分析揭示了调控脂质、脑容量和自噬的基因位点

2026-04-210
OAAI
Author Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans

作者更正:食用改良的地中海生酮饮食可逆转人类阿尔茨海默病的外周脂质特征

2026-04-060
OAAI
A Bayesian classification model for differential diagnosis of Alzheimer's disease and frontotemporal dementia using plasma biomarkers

基于血浆生物标志物的阿尔茨海默病和额颞叶痴呆鉴别诊断的贝叶斯分类模型

2026-04-060
PRE
Physical activity across the life course and neural biomarkers

生命历程中的身体活动与神经生物标志物

2026-02-230
PRE
N-Truncated Superoxide Dismutase-1 in Cerebrospinal Fluid Is Folded and Active

脑脊液中截断型超氧化物歧化酶-1是折叠且具有活性的

2026-02-100
OAAI
Biomarker-integrated prognostic stagings for Alzheimer’s Disease

阿尔茨海默病的生物标志物综合预后分期

2026-02-020
OAAI
Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer’s disease mutations

常染色体显性遗传阿尔茨海默病突变的瑞典家庭的早期功能变化和血浆GFAP

2026-01-270
OAAI
Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use

血浆pTau217的双重截止策略,以预测跨多个测定平台的Tau PET阳性: Tau富集和Tau稀缺的队列,以实现具有成本效益的临床使用

2026-01-140
OAAI
Inflammation‐related proteomic changes in response to amyloid and tau pathologies

对淀粉样蛋白和tau病理学反应的炎症相关蛋白质组变化

2026-01-080
OA
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology

一种微创的干血斑生物标志物检测方法,用于检测阿尔茨海默病的病理学

2026-01-050
OAAI
Microglia as a key player in Aβ‐related astrocyte reactivity

小胶质细胞作为Aβ相关星形胶质细胞反应性的关键参与者

2025-12-250
OAAI